Latest market price
44.25
-0.83-1.84%
ELVNQT76Enliven Therapeutics, Inc.·NASDAQ
44.25-1.84%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 21, 20264Statement of changes in beneficial ownership
Oct 21, 20264Statement of changes in beneficial ownership
Oct 16, 20264Statement of changes in beneficial ownership
Oct 16, 20263Initial statement of beneficial ownership
Oct 14, 20268-KCurrent report
Oct 05, 20264Statement of changes in beneficial ownership
Sep 21, 20264Statement of changes in beneficial ownership
Sep 21, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 19, 20264Statement of changes in beneficial ownership
Aug 06, 20264Statement of changes in beneficial ownership
Aug 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 05, 202610-QQuarterly report
Aug 05, 20268-KCurrent report
Jul 21, 20264Statement of changes in beneficial ownership
Jul 21, 20264Statement of changes in beneficial ownership
Jul 08, 20264Statement of changes in beneficial ownership
Jun 24, 20264Statement of changes in beneficial ownership
Jun 24, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 20264Statement of changes in beneficial ownership
Jun 22, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 2026SC 13D/ABeneficial ownership statement (active, amended)